MAM
Yamaha Motor India to continue with John Abraham as its brand endorser
MUMBAI: Yamaha Motor India today announced an extension of its association with Bollywood’s heartthrob, versatile actor and biking enthusiast Mr. John Abraham. The company has again renewed its association with the popular youth icon by extending the contract for two more years.
While John will continue to endorse Yamaha’s flagship motorcycle brands, Deepika will simultaneously endorse the scooter section of Yamaha. Yamaha Motors India strongly believes that they will further strengthen the brand appeal of Yamaha’s strong product line-up.
Commenting on the occasion, Mr. Roy Kurian, Vice President – Sales & Marketing, Yamaha Motor India Sales Pvt. Ltd. said, “Our association with John goes back a long way and he has done a commendable job for us. He has been the face of Yamaha since 2005 now. An avid biker himself, John personifies the true DNA of Yamaha which stands for power, speed, ruggedness and great style. Hence, our target audience relates to him and he remains to be the perfect face for Yamaha. We are upbeat about our association with John and are confident that it will catapult the concept of biking in India to an all new level.”
Talking about the association, John Abraham shared, ”I am excited about the association with Yamaha yet again. The company is doing a great job not only by introducing powerful and stylish products but also by its unique initiatives to promote biking/racing in India and spreading awareness on safety.”
John Abraham will also be marking his presence at the Auto Expo 2014 at India Expo Mart, Greater Noida.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
